Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Program Update topic
No spam. Unsubscribe anytime.
Connecticut medical-marijuana program reports 40,000 patients, new microcultivators and limited near-term impact from federal rescheduling
Summary
Program staff told the state Board of Physicians the medical marijuana program has about 40,000 patients and 1,808 certifying physicians, several new microcultivators are coming online and federal rescheduling to Schedule III is unlikely to disrupt Connecticut’s medical program in the short term.
The Connecticut Medical Marijuana Program told the Board of Physicians that the state’s patient registry has about 40,000 patients and 1,808 certifying physicians, and that several new cultivators are beginning operations.
Rod Marriott, the program’s drug control director, said the industry’s supply has been expanding as legacy producers increase output and new microcultivators and disproportionately impacted-area cultivators come online. “We have had two new microcultivators approved for final licensure in the last few months,” Marriott said, and one has already applied to expand.
Why it matters: the board suggested the additional small cultivators should diversify supply and reduce time lags between license approval and product availability at dispensaries.
Marriott described the Drug Enforcement Administration rescheduling process as long and iterative, with time for public comment and agency review. “Rescheduling is a long process,” he said. He told the board the program’s initial assessment is that a move to federal Schedule III would have “very minimal, if any” immediate impact on Connecticut’s medical marijuana program, though it could produce tax or banking benefits for businesses.
Board members asked about banking and whether rescheduling would ease financial barriers for producers and dispensaries. Marriott said banking changes would require a formal rescheduling to Schedule III or separate federal legislation; both are controlled outside the program. On where to find licensed cultivators, Marriott said licensing details are posted on the program’s online licensing portal and that staff can provide a specific list on request.
The board also discussed licensing tiers. Marriott described the microcultivator tier as a smaller license class with an initial floor of roughly 2,000 square feet and an initial cap of about 10,000 square feet of gross space; full cultivators have a minimum of 15,000 square feet as prescribed in state statute or law. Board members asked about product innovations: staff said facilities will be able to make infused beverages under the adult-use framework, with a July 1 cap of 3 milligrams of THC per container and a minimum container size of 12 ounces for those capped hemp-style beverages; staff said those products will be age-gated and available only through licensed cannabis retailers.
No formal action was taken by the board on these updates; staff presented information and answered members’ questions.
The board moved on to public hearings on petitions to add debilitating conditions following the program update.
